Form 4: Director Kathleen Starkoff Receives Gentex Equity Grant

Gentex Corporation director Kathleen Starkoff was granted 5,626 shares of common stock as part of a standard equity compensation award.

Summary

• Director Kathleen Starkoff acquired 5,626 shares of Gentex Corporation (GNTX) common stock on May 21, 2026.
• The shares were granted at a price of $0.00, representing an equity compensation award.
• Following this transaction, Starkoff's total beneficial ownership in the company increased to 36,770 shares.
• The granted shares are subject to a 100% vesting schedule one year from the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increase in total beneficial ownership by a member of the board.

Negatives

• None identified.

Risks

• The shares are subject to a one-year vesting period, meaning the director does not have immediate liquidity or full ownership rights until the vesting date.

Future Outlook

The shares granted will vest in full on May 21, 2027, one year from the grant date.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the automotive technology sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The grant of equity to directors is consistent with standard compensation practices for S&P 400 and similar mid-cap industrial companies.
• The one-year cliff vesting period is a common retention and alignment mechanism used by peers in the automotive supply industry.

Stakeholder Impact

• Shareholders: Positive alignment as director compensation is tied to equity performance.

Next Steps

• Vesting of the 5,626 shares on May 21, 2027.

Key Dates

Keywords

Gentex, GNTX, Director, Equity Grant, Insider Transaction, SEC Form 4